| Symbol |
Name |
Standardized Value |
|
RBP3
|
retinol binding protein 3, interstitial
|
3.018
|
|
TNF
|
tumor necrosis factor
|
2.872
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
2.796
|
|
CD4
|
CD4 molecule
|
2.685
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.668
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
2.661
|
|
IL17A
|
interleukin 17A
|
2.656
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
2.649
|
|
ACE
|
angiotensin I converting enzyme
|
2.629
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
2.599
|
|
IL6
|
interleukin 6
|
2.592
|
|
IFNG
|
interferon, gamma
|
2.547
|
|
IL1B
|
interleukin 1, beta
|
2.463
|
|
IL10
|
interleukin 10
|
2.442
|
|
CD8A
|
CD8a molecule
|
2.409
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
2.405
|
|
IL23R
|
interleukin 23 receptor
|
2.397
|
|
MRAP
|
melanocortin 2 receptor accessory protein
|
2.374
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
2.333
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
2.318
|
|
IL1A
|
interleukin 1, alpha
|
2.293
|
|
IL2
|
interleukin 2
|
2.259
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
2.254
|
|
IFNA1
|
interferon, alpha 1
|
2.184
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
2.132
|
|
CAPN5
|
calpain 5
|
2.106
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
2.071
|
|
IFNA2
|
interferon, alpha 2
|
2.034
|
|
PRTN3
|
proteinase 3
|
2.02
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
2.014
|
|
RCVRN
|
recoverin
|
2.013
|
|
IL4
|
interleukin 4
|
1.987
|
|
IFNA8
|
interferon, alpha 8
|
1.985
|
|
IFNA16
|
interferon, alpha 16
|
1.984
|
|
IFNA5
|
interferon, alpha 5
|
1.984
|
|
IFNA7
|
interferon, alpha 7
|
1.983
|
|
IFNA21
|
interferon, alpha 21
|
1.983
|
|
IFNA4
|
interferon, alpha 4
|
1.983
|
|
IFNA14
|
interferon, alpha 14
|
1.983
|
|
IFNA10
|
interferon, alpha 10
|
1.983
|
|
IFNA6
|
interferon, alpha 6
|
1.982
|
|
IFNA13
|
interferon, alpha 13
|
1.98
|
|
IFNA17
|
interferon, alpha 17
|
1.979
|
|
TLR4
|
toll-like receptor 4
|
1.966
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.939
|
|
C1ORF141
|
chromosome 1 open reading frame 141
|
1.939
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
1.938
|
|
IL22
|
interleukin 22
|
1.934
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.933
|
|
ALB
|
albumin
|
1.921
|
|
B2M
|
beta-2-microglobulin
|
1.914
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
1.899
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.896
|
|
IL18
|
interleukin 18
|
1.881
|
|
MEFV
|
Mediterranean fever
|
1.862
|
|
IL17F
|
interleukin 17F
|
1.842
|
|
CFH
|
complement factor H
|
1.834
|
|
CD80
|
CD80 molecule
|
1.83
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.82
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.788
|
|
FOXP3
|
forkhead box P3
|
1.783
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
1.768
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.765
|
|
CD68
|
CD68 molecule
|
1.761
|
|
CARD9
|
caspase recruitment domain family, member 9
|
1.742
|
|
MPO
|
myeloperoxidase
|
1.739
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.731
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
1.728
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
1.724
|
|
TLR2
|
toll-like receptor 2
|
1.724
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.719
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.718
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.712
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.704
|
|
TYR
|
tyrosinase
|
1.692
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
1.685
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
1.679
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.677
|
|
IL5
|
interleukin 5
|
1.675
|
|
CD19
|
CD19 molecule
|
1.657
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.652
|
|
CD28
|
CD28 molecule
|
1.648
|
|
IL13
|
interleukin 13
|
1.64
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
1.639
|
|
TYK2
|
tyrosine kinase 2
|
1.638
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.624
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.619
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.611
|
|
CFB
|
complement factor B
|
1.607
|
|
MBP
|
myelin basic protein
|
1.607
|
|
CD86
|
CD86 molecule
|
1.605
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.604
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.604
|
|
LTA
|
lymphotoxin alpha
|
1.603
|
|
TGFB2
|
transforming growth factor, beta 2
|
1.601
|
|
STAT4
|
signal transducer and activator of transcription 4
|
1.595
|
|
ANTXR2
|
anthrax toxin receptor 2
|
1.594
|
|
C3
|
complement component 3
|
1.588
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
1.587
|
|
KLRC4
|
killer cell lectin-like receptor subfamily C, member 4
|
1.587
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
1.586
|
|
CD274
|
CD274 molecule
|
1.585
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
1.585
|
|
PDCD1
|
programmed cell death 1
|
1.577
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
1.574
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.574
|
|
MMP9
|
matrix metallopeptidase 9
|
1.565
|
|
RHO
|
rhodopsin
|
1.563
|
|
MVK
|
mevalonate kinase
|
1.561
|
|
JAK1
|
Janus kinase 1
|
1.555
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.55
|
|
IL6R
|
interleukin 6 receptor
|
1.549
|
|
IL15
|
interleukin 15
|
1.542
|
|
S100A12
|
S100 calcium binding protein A12
|
1.538
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.537
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.532
|
|
SAA1
|
serum amyloid A1
|
1.523
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.523
|
|
PMEL
|
premelanosome protein
|
1.521
|
|
SAA2
|
serum amyloid A2
|
1.52
|
|
POMC
|
proopiomelanocortin
|
1.514
|
|
TBX21
|
T-box 21
|
1.511
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.506
|
|
TLR3
|
toll-like receptor 3
|
1.502
|
|
INS
|
insulin
|
1.495
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
1.494
|
|
IL17RA
|
interleukin 17 receptor A
|
1.493
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.489
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.486
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
1.484
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.473
|
|
NELFCD
|
negative elongation factor complex member C/D
|
1.472
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.471
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.469
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.465
|
|
KIF21B
|
kinesin family member 21B
|
1.463
|
|
AIRE
|
autoimmune regulator
|
1.461
|
|
IL7
|
interleukin 7
|
1.461
|
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1
|
1.46
|
|
MMP3
|
matrix metallopeptidase 3
|
1.46
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.456
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.45
|
|
LTF
|
lactotransferrin
|
1.445
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.439
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.439
|
|
CD40LG
|
CD40 ligand
|
1.438
|
|
EYS
|
eyes shut homolog (Drosophila)
|
1.438
|
|
JAK2
|
Janus kinase 2
|
1.436
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
1.434
|
|
UBAC2
|
UBA domain containing 2
|
1.431
|
|
RLBP1
|
retinaldehyde binding protein 1
|
1.429
|
|
HEYL
|
hes-related family bHLH transcription factor with YRPW motif-like
|
1.421
|
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats
|
1.421
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.418
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
1.412
|
|
AIF1
|
allograft inflammatory factor 1
|
1.407
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.406
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
1.404
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.397
|
|
ACTB
|
actin, beta
|
1.394
|
|
WDR11
|
WD repeat domain 11
|
1.389
|
|
FN1
|
fibronectin 1
|
1.389
|
|
IL9
|
interleukin 9
|
1.376
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
1.375
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
1.366
|
|
RS1
|
retinoschisin 1
|
1.365
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
1.363
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.359
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.356
|
|
DHFR2
|
dihydrofolate reductase 2
|
1.356
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
1.352
|
|
SELE
|
selectin E
|
1.348
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.347
|
|
IL18R1
|
interleukin 18 receptor 1
|
1.345
|
|
IL33
|
interleukin 33
|
1.343
|
|
IL1R2
|
interleukin 1 receptor, type II
|
1.342
|
|
LACRT
|
lacritin
|
1.341
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.34
|
|
CA1
|
carbonic anhydrase I
|
1.331
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.324
|
|
BEST1
|
bestrophin 1
|
1.322
|
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
1.321
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
1.321
|
|
CD5
|
CD5 molecule
|
1.32
|
|
FANCC
|
Fanconi anemia, complementation group C
|
1.316
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.314
|
|
TLR9
|
toll-like receptor 9
|
1.31
|
|
CRYBB1
|
crystallin, beta B1
|
1.31
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.307
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
1.304
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.302
|
|
IL37
|
interleukin 37
|
1.302
|
|
DHFR
|
dihydrofolate reductase
|
1.3
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
1.3
|
|
PLAT
|
plasminogen activator, tissue
|
1.297
|
|
CFHR2
|
complement factor H-related 2
|
1.296
|
|
SRSF6
|
serine/arginine-rich splicing factor 6
|
1.293
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
1.291
|
|
LACC1
|
laccase (multicopper oxidoreductase) domain containing 1
|
1.288
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.286
|
|
CD27
|
CD27 molecule
|
1.284
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
1.275
|
|
BCR
|
breakpoint cluster region
|
1.272
|
|
PXDN
|
peroxidasin
|
1.272
|
|
PXDNL
|
peroxidasin-like
|
1.269
|
|
TJP1
|
tight junction protein 1
|
1.269
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
1.267
|
|
PDC
|
phosducin
|
1.267
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
1.265
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
1.263
|
|
LY96
|
lymphocyte antigen 96
|
1.26
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.26
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
1.257
|
|
TRIM21
|
tripartite motif containing 21
|
1.257
|
|
SELL
|
selectin L
|
1.257
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
1.256
|
|
ENO1
|
enolase 1, (alpha)
|
1.254
|
|
TOR1B
|
torsin family 1, member B (torsin B)
|
1.252
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.25
|
|
CD1C
|
CD1c molecule
|
1.248
|
|
LPIN2
|
lipin 2
|
1.246
|
|
ADA2
|
adenosine deaminase 2
|
1.244
|
|
IRF8
|
interferon regulatory factor 8
|
1.244
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.243
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.242
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
1.241
|
|
JAK3
|
Janus kinase 3
|
1.241
|
|
CD163
|
CD163 molecule
|
1.233
|
|
RUNX3
|
runt-related transcription factor 3
|
1.233
|
|
RORC
|
RAR-related orphan receptor C
|
1.231
|
|
F2
|
coagulation factor II (thrombin)
|
1.23
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.229
|
|
MMP1
|
matrix metallopeptidase 1
|
1.228
|
|
CD69
|
CD69 molecule
|
1.225
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.224
|
|
IFNL1
|
interferon, lambda 1
|
1.223
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
1.218
|
|
CD52
|
CD52 molecule
|
1.218
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
1.217
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
1.215
|
|
C2
|
complement component 2
|
1.213
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
1.203
|
|
IL36R
|
interleukin 36 receptor
|
1.197
|
|
VASN
|
vasorin
|
1.195
|
|
TLR7
|
toll-like receptor 7
|
1.192
|
|
PGF
|
placental growth factor
|
1.19
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.186
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.18
|
|
OCLN
|
occludin
|
1.175
|
|
IL7R
|
interleukin 7 receptor
|
1.174
|
|
OPTC
|
opticin
|
1.173
|
|
CNTF
|
ciliary neurotrophic factor
|
1.171
|
|
CD276
|
CD276 molecule
|
1.171
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
1.168
|
|
JUN
|
jun proto-oncogene
|
1.167
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
1.164
|
|
TMEM134
|
transmembrane protein 134
|
1.162
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.161
|
|
TAC1
|
tachykinin, precursor 1
|
1.16
|
|
CA2
|
carbonic anhydrase II
|
1.159
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.158
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.156
|
|
EGR2
|
early growth response 2
|
1.152
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
1.152
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
1.15
|
|
TPO
|
thyroid peroxidase
|
1.149
|
|
CFI
|
complement factor I
|
1.149
|
|
LCN2
|
lipocalin 2
|
1.147
|
|
HP
|
haptoglobin
|
1.147
|
|
MMP8
|
matrix metallopeptidase 8
|
1.147
|
|
KDR
|
kinase insert domain receptor
|
1.144
|
|
C5
|
complement component 5
|
1.144
|
|
FBXO22
|
F-box protein 22
|
1.142
|
|
C4B
|
complement component 4B (Chido blood group)
|
1.14
|
|
TNRC18
|
trinucleotide repeat containing 18
|
1.138
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
1.137
|
|
TRIM45
|
tripartite motif containing 45
|
1.137
|
|
CRYGS
|
crystallin, gamma S
|
1.135
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
1.134
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
1.132
|
|
IL1F10
|
interleukin 1 family, member 10 (theta)
|
1.132
|
|
TYRP1
|
tyrosinase-related protein 1
|
1.132
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
1.13
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.13
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
1.125
|
|
TLR1
|
toll-like receptor 1
|
1.124
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
1.122
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
1.119
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.118
|
|
HMGB1
|
high mobility group box 1
|
1.117
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
1.114
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
1.113
|
|
S100A9
|
S100 calcium binding protein A9
|
1.113
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.112
|
|
MMP2
|
matrix metallopeptidase 2
|
1.112
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
1.111
|
|
EGF
|
epidermal growth factor
|
1.11
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
1.108
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.107
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.107
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.104
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.104
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.104
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.103
|
|
FGF7
|
fibroblast growth factor 7
|
1.102
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.101
|
|
EDNRA
|
endothelin receptor type A
|
1.101
|
|
P3H3
|
prolyl 3-hydroxylase 3
|
1.101
|
|
ELANE
|
elastase, neutrophil expressed
|
1.1
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
1.099
|
|
TAPBP
|
TAP binding protein (tapasin)
|
1.096
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
1.096
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
1.093
|
|
CD2
|
CD2 molecule
|
1.089
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
1.087
|
|
PLG
|
plasminogen
|
1.087
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
1.085
|
|
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific)
|
1.084
|
|
CD1D
|
CD1d molecule
|
1.083
|
|
CD22
|
CD22 molecule
|
1.081
|
|
CD200
|
CD200 molecule
|
1.08
|
|
ANGPT2
|
angiopoietin 2
|
1.079
|
|
IL27
|
interleukin 27
|
1.077
|
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta
|
1.075
|
|
HRH2
|
histamine receptor H2
|
1.075
|
|
MME
|
membrane metallo-endopeptidase
|
1.072
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
1.071
|
|
PFDN5
|
prefoldin subunit 5
|
1.069
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.069
|
|
CD1B
|
CD1b molecule
|
1.067
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
1.067
|
|
CD1E
|
CD1e molecule
|
1.067
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.066
|
|
GPR25
|
G protein-coupled receptor 25
|
1.066
|
|
IL31
|
interleukin 31
|
1.066
|
|
H2BC21
|
H2B clustered histone 21
|
1.065
|
|
GPR35
|
G protein-coupled receptor 35
|
1.063
|
|
KIFAP3
|
kinesin-associated protein 3
|
1.061
|
|
TECPR2
|
tectonin beta-propeller repeat containing 2
|
1.06
|
|
IL26
|
interleukin 26
|
1.06
|
|
REN
|
renin
|
1.06
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.058
|
|
IL17RC
|
interleukin 17 receptor C
|
1.058
|
|
CD1A
|
CD1a molecule
|
1.056
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
1.053
|
|
INAVA
|
innate immunity activator
|
1.052
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
1.048
|
|
HSPA4
|
heat shock 70kDa protein 4
|
1.047
|
|
CISH
|
cytokine inducible SH2-containing protein
|
1.046
|
|
CD200R1
|
CD200 receptor 1
|
1.045
|
|
ORM1
|
orosomucoid 1
|
1.042
|
|
HMOX1
|
heme oxygenase 1
|
1.038
|
|
FGF5
|
fibroblast growth factor 5
|
1.034
|
|
FGF4
|
fibroblast growth factor 4
|
1.031
|
|
FGF22
|
fibroblast growth factor 22
|
1.031
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.03
|
|
FGF16
|
fibroblast growth factor 16
|
1.03
|
|
FGF3
|
fibroblast growth factor 3
|
1.029
|
|
FGF6
|
fibroblast growth factor 6
|
1.029
|
|
FGF20
|
fibroblast growth factor 20
|
1.027
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
1.027
|
|
NPEPPS
|
aminopeptidase puromycin sensitive
|
1.026
|
|
BTNL2
|
butyrophilin-like 2
|
1.026
|
|
CKB
|
creatine kinase, brain
|
1.025
|
|
FGF17
|
fibroblast growth factor 17
|
1.025
|
|
FGF9
|
fibroblast growth factor 9
|
1.024
|
|
IL2RB
|
interleukin 2 receptor, beta
|
1.021
|
|
SDC1
|
syndecan 1
|
1.021
|
|
FGF18
|
fibroblast growth factor 18
|
1.021
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
1.021
|
|
ACKR2
|
atypical chemokine receptor 2
|
1.019
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.018
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.017
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
1.016
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.016
|
|
IL3
|
interleukin 3
|
1.015
|
|
FGF10
|
fibroblast growth factor 10
|
1.014
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
1.014
|
|
KRT12
|
keratin 12, type I
|
1.013
|
|
CARD14
|
caspase recruitment domain family, member 14
|
1.013
|
|
CKM
|
creatine kinase, muscle
|
1.013
|
|
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae)
|
1.01
|
|
THBS1
|
thrombospondin 1
|
1.01
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
1.01
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.006
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.004
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.003
|
|
ORM2
|
orosomucoid 2
|
1.003
|
|
TTR
|
transthyretin
|
1.002
|
|
TLR5
|
toll-like receptor 5
|
1.0
|
